AI decision support for detecting skin cancer in primary care

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a cluster-randomized trial conducted at about 30 primary care centers across Sweden, Germany, Scotland, the Netherlands, and Australia. Participating centers are randomized to either use the Dermalyser AI decision support tool or continue standard clinical assessment. The trial prospectively compares diagnostic accuracy, reliability, and clinical utility of the AI-assisted pathway versus usual care for patients presenting with suspicious skin lesions. Outcomes will capture how well the tool distinguishes malignant from benign lesions and how it affects clinical decisions in routine primary care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients attending a primary care facility in order to have one or more skin lesions checked for skin cancer, or patients presenting with one or more skin lesions raising suspicion of skin cancer when noticed by the primary care physician.
* Willingness and ability to provide informed consent.

Exclusion Criteria:

* Individuals with skin type V and VI according to the Fitzpatrick's scale (darker brown or black coloured skin)

Where it's running

• Finspång Primary Healthcare Centre
  Finspång, Docent, Sweden Recruiting
• Valla Primary Healthcare Centre
  Linköping, Docent, Sweden Recruiting
• Kärna Primary Care Centre
  Linköping, Docent, Sweden Recruiting
• Mjölby Primary Care Centre
  Mjölby, Docent, Sweden Recruiting
• Vikbolandet Primary Care Centre
  Norrköping, Docent, Sweden Recruiting
• Åby Primary Healthcare Centre
  Norrköping, Docent, Sweden Recruiting

Study contacts

• Study coordinator: Magnus Falk, Professor
• Email: magnus.falk@liu.se
• Phone: +46708106176

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Mobile sun protection support to help young adults stay safe in the sun

  This project tests a mobile health program to see if reminders, education, planning tools, and real-time sun exposure information can help young adults protect their skin from excessive sun exposure.

  Recruiting University of Utah · Salt Lake City, Utah · NCT07830394

• Psycho-physiological profiling of people with low versus high heat resilience

  This project will test whether controlled heat and UV exposures plus physiological and psychological measurements can identify healthy adults who are more or less resilient to heat.

  Recruiting at 2 sites University of Thessaly · Copenhagen and 1 other locations · NCT07510061

• Cosibelimab for tough CSCC in kidney transplant recipients or blood cancers

  This trial tests cosibelimab in people with advanced cutaneous squamous cell carcinoma who have a kidney transplant or certain blood cancers to see if it is safe and helpful for them.

  Recruiting at 2 sites Phase 4 Dana-Farber Cancer Institute · Boston, Massachusetts and 1 other locations · NCT07426484

• First-line immunotherapy and PD-L1 testing for metastatic melanoma in Slovenia

  This study will see if first-line immunotherapy (pembrolizumab, nivolumab, or ipilimumab plus nivolumab) works for adults in Slovenia with metastatic melanoma and whether PD-L1 measurements predict who responds.

  Recruiting Institute of Oncology Ljubljana · Ljubljana · NCT07422779

• Optical and multi-modal analysis to help diagnose skin cancer

  This project tests whether combining optical spectroscopy and imaging data from skin samples can help diagnose skin cancer in people with skin concerns.

  Recruiting Centre Hospitalier Régional Metz-Thionville · Metz · NCT07406022

• Early skin tumor detection with telemedicine in primary care

  This project will test whether a telemedicine tool used by general practitioners can help detect suspicious skin lesions earlier in people with fair skin in the Czech Republic.

  Recruiting at 2 sites Institute of Health Information and Statistics of the Czech Republic · Brno and 4 other locations · NCT07349940

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.